Simple gene technique changes sex of a mouse
By Steve Connor,
The Independent
| 12. 11. 2009
From Minnie to Mickey (and all they did was turn off a gene)
The battle of the sexes is a never-ending war waged within ourselves
as male and female elements of our own bodies continually fight each
other for supremacy. This is the astonishing implication of a
pioneering study showing that it is possible to flick a genetic switch
that turns female ovary cells into male testicular tissue.
For
decades, the battle of the sexes has been accepted by biologists as a
real phenomenon with males and females competing against each other -
when their interests do not coincide - for the continued survival of
their genes in the next generation. Now scientists have been able to
show that a gender war is constantly raging between the genes and cells
of one individual.
One of the great dogmas of biology is that
gender is fixed from birth, determined by the inheritance of certain
genes on the X and Y sex chromosomes. But this simplistic idea has been
exploded by the latest study, which demonstrated that fully-developed
adult females can undergo a partial sex change following a genetic
modification to a single gene.
The...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...